Recurrent Drug-induced Liver Injury

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Recurrent Drug-induced Liver Injury trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT01793168

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…

United States, Australia20,000 participantsStarted 2010-07

All recent trials (4 shown)

Active — Not RecruitingNot Applicable

NCT06547229

Clinicopathological Features and Genetic Susceptibility Screening of Recurrent Drug-induced Liver Injury

The goal of this observational study is to screening for clinical, pathological and HLA features in patients with recurrent drug-induced liver injury. The main…

China60 participantsStarted 2024-07-15

CompletedPhase 1/2

NCT03266146

36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI

This study is to observe the efficacy and safety of 36 weeks short-term optimization treatment of glucocorticosteroid in the patients with chronic recurrent dru…

China90 participantsStarted 2017-09-02

Treatment: 36 Weeks Methylprednisolone, 48 weeks Methylprednisolone

Recurrent Drug-induced Liver Injury

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

All recent trials (4 shown)

Clinicopathological Features and Genetic Susceptibility Screening of Recurrent Drug-induced Liver Injury

36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

All recent trials (4 shown)

Clinicopathological Features and Genetic Susceptibility Screening of Recurrent Drug-induced Liver Injury

36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI

Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILI